TechCrunch Mobility: It doesn’t matter that people hate the Ferrari Luce
Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part.
Business news from Google News (RapidAPI).
7114 articles
Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, how AI is playing a part.
While tech is still leading the party, more parts of the market are starting to join in.
A white picket fence in the front yard once signified middle-class neighborliness. But hardly anyone buys them anymore.
Jes Staley has agreed to be interviewed on July 23 by the House Oversight and Government Reform Committee about his late friend, the sex offender Jeffrey...
Blue Origin's New Glenn rocket exploded during a hot-fire test, and Elon Musk had some thoughts about it as SpaceX heads toward what could be the biggest...
Inflation has a way of turning economics into personal finance. For retirees living on fixed incomes, every increase in the price of groceries, gasoline,...
A bill moving through Congress could bar the 137-year-old luxury icon from American roads.
Experts say that student loan borrowers should proceed with caution when taking on more debt or consolidating after July 1, due to upcoming changes.
Kohl's continues to struggle to capture consumer spending as department store chains nationwide see weaker demand. Amid this trend, Kohl's is introducing...
The image supposedly shows a locked chain and strap tying an employee's ankle to a food preparation station.
Chipmakers are by far the hottest stocks in the market, but their recent surge is lending urgency to the debate over whether investors are buying into an...
The scramble for electricity has become the gold rush beneath the AI boom.
By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.
It's impossible to understand American politics without also understanding the American economy (and vice versa). Politics and economics may be different...
Lawmakers and some investors are warning about the growing reliance of US pharmaceutical companies on China, raising the prospect of national security...
It's the moment of truth for Akeso's ivonescimab, and to many, a high-stakes test for China's booming biotech industry. And the first-in-class PD-1xVEGF...
A quiet Friday announcement just reshaped the pitch for the year's biggest stock debut.
Oil prices have cooled off over the past couple of weeks due to optimism that the U.S. and Iran are close to a peace deal that would reopen the Strait of...
"I apologize for not dying soon enough for you," one boomer wrote to me, "so your generation can pick over my financial bones."
Hiring has surpassed expectations in recent months, but economists are divided on what the data means.